Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1944 1
1946 2
1947 2
1948 5
1949 3
1950 10
1951 8
1952 11
1953 4
1954 7
1955 7
1956 6
1957 7
1958 9
1959 8
1960 6
1961 9
1962 13
1963 15
1964 5
1965 8
1966 5
1967 10
1968 6
1969 6
1970 2
1971 5
1972 5
1973 7
1974 11
1975 5
1976 2
1977 5
1978 7
1979 9
1980 6
1981 10
1982 6
1983 4
1984 8
1985 10
1986 8
1987 11
1988 8
1989 15
1990 9
1991 12
1992 6
1993 8
1994 11
1995 7
1996 13
1997 11
1998 8
1999 6
2000 14
2001 23
2002 17
2003 16
2004 20
2005 23
2006 10
2007 14
2008 12
2009 8
2010 17
2011 32
2012 28
2013 30
2014 34
2015 31
2016 37
2017 53
2018 59
2019 54
2020 48
2021 35
Text availability
Article attribute
Article type
Publication date

Search Results

993 results
Results by year
Filters applied: . Clear all
Page 1
Single-cell metabolic profiling of human cytotoxic T cells.
Hartmann FJ, Mrdjen D, McCaffrey E, Glass DR, Greenwald NF, Bharadwaj A, Khair Z, Verberk SGS, Baranski A, Baskar R, Graf W, Van Valen D, Van den Bossche J, Angelo M, Bendall SC. Hartmann FJ, et al. Nat Biotechnol. 2021 Feb;39(2):186-197. doi: 10.1038/s41587-020-0651-8. Epub 2020 Aug 31. Nat Biotechnol. 2021. PMID: 32868913 Free PMC article.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Poeschel V, Held G, Ziepert M, Witzens-Harig M, Holte H, Thurner L, Borchmann P, Viardot A, Soekler M, Keller U, Schmidt C, Truemper L, Mahlberg R, Marks R, Hoeffkes HG, Metzner B, Dierlamm J, Frickhofen N, Haenel M, Neubauer A, Kneba M, Merli F, Tucci A, de Nully Brown P, Federico M, Lengfelder E, di Rocco A, Trappe R, Rosenwald A, Berdel C, Maisenhoelder M, Shpilberg O, Amam J, Christofyllakis K, Hartmann F, Murawski N, Stilgenbauer S, Nickelsen M, Wulf G, Glass B, Schmitz N, Altmann B, Loeffler M, Pfreundschuh M; FLYER Trial Investigators; German Lymphoma Alliance. Poeschel V, et al. Among authors: hartmann f. Lancet. 2019 Dec 21;394(10216):2271-2281. doi: 10.1016/S0140-6736(19)33008-9. Lancet. 2019. PMID: 31868632 Clinical Trial.
An Integrated Multi-omic Single-Cell Atlas of Human B Cell Identity.
Glass DR, Tsai AG, Oliveria JP, Hartmann FJ, Kimmey SC, Calderon AA, Borges L, Glass MC, Wagar LE, Davis MM, Bendall SC. Glass DR, et al. Among authors: hartmann fj. Immunity. 2020 Jul 14;53(1):217-232.e5. doi: 10.1016/j.immuni.2020.06.013. Immunity. 2020. PMID: 32668225 Free PMC article.
Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy.
Hartmann FJ, Babdor J, Gherardini PF, Amir ED, Jones K, Sahaf B, Marquez DM, Krutzik P, O'Donnell E, Sigal N, Maecker HT, Meyer E, Spitzer MH, Bendall SC. Hartmann FJ, et al. Cell Rep. 2019 Jul 16;28(3):819-831.e4. doi: 10.1016/j.celrep.2019.06.049. Cell Rep. 2019. PMID: 31315057 Free PMC article.
Association of Checkpoint Inhibitor-Induced Toxic Effects With Shared Cancer and Tissue Antigens in Non-Small Cell Lung Cancer.
Berner F, Bomze D, Diem S, Ali OH, Fässler M, Ring S, Niederer R, Ackermann CJ, Baumgaertner P, Pikor N, Cruz CG, van de Veen W, Akdis M, Nikolaev S, Läubli H, Zippelius A, Hartmann F, Cheng HW, Hönger G, Recher M, Goldman J, Cozzio A, Früh M, Neefjes J, Driessen C, Ludewig B, Hegazy AN, Jochum W, Speiser DE, Flatz L. Berner F, et al. Among authors: hartmann f. JAMA Oncol. 2019 Jul 1;5(7):1043-1047. doi: 10.1001/jamaoncol.2019.0402. JAMA Oncol. 2019. PMID: 31021392 Free PMC article. Clinical Trial.
993 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page